Emmanuel Laryea
Overview
Explore the profile of Emmanuel Laryea including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
21
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamming L, Duque D, Tran A, Lansdell C, Frahm G, Wu J, et al.
Mol Ther Methods Clin Dev
. 2025 Jan;
33(1):101388.
PMID: 39759470
[This corrects the article DOI: 10.1016/j.omtm.2024.101325.].
2.
Tamming L, Duque D, Bavananthasivam J, Tran A, Lansdell C, Frahm G, et al.
Mol Ther Methods Clin Dev
. 2024 Sep;
32(3):101325.
PMID: 39309757
The effectiveness of mRNA vaccines largely depends on their lipid nanoparticle (LNP) component. Herein, we investigate the effectiveness of DLin-KC2-DMA (KC2) and SM-102-based LNPs for the intramuscular delivery of a...
3.
Pfeifle A, Thulasi Raman S, Lansdell C, Zhang W, Tamming L, Cecillon J, et al.
Front Immunol
. 2023 Apr;
14:1020134.
PMID: 37006299
Introduction: The incidence of Lyme disease (LD) in Canada and the United States has risen over the last decade, nearing 480,000 cases each year. sensu lato, the causative agent of...
4.
Tamming L, Duque D, Tran A, Zhang W, Pfeifle A, Laryea E, et al.
Front Immunol
. 2022 Jan;
12:785349.
PMID: 35095861
SARS-CoV-2 infections present a tremendous threat to public health. Safe and efficacious vaccines are the most effective means in preventing the infections. A variety of vaccines have demonstrated excellent efficacy...